The NICU Antibiotics and Outcomes (NANO) trial: a randomized multicenter clinical trial assessing empiric antibiotics and clinical outcomes in newborn preterm infants

BACKGROUND: Early-onset sepsis is an important cause of neonatal morbidity and mortality in the preterm population. Infants perceived to be at increased risk for early-onset sepsis are often treated empirically with broad-spectrum antibiotics while awaiting confirmatory blood cultures, despite an ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Morowitz, Michael J., Katheria, Anup C., Polin, Richard A., Pace, Elizabeth, Huang, David T., Chang, Chung-Chou H., Yabes, Johathan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125935/
https://www.ncbi.nlm.nih.gov/pubmed/35606829
http://dx.doi.org/10.1186/s13063-022-06352-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125935/
https://www.ncbi.nlm.nih.gov/pubmed/35606829
http://dx.doi.org/10.1186/s13063-022-06352-3

Ejemplares similares